Ibaraki, Japan

Yukiko Sugaya

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Eisai Company, Limited. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukiko Sugaya. Retrieved from https://idiyas.com/inventor/yukiko-sugaya-ge9mqbf5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
4 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'd be delighted to assist you with the article about inventor Yukiko Sugaya from Ibaraki, Japan, who holds 4 patents.

Title: Innovator Spotlight: Yukiko Sugaya - Pioneer in Antidementia Medicaments

Introduction: Yukiko Sugaya, a prolific inventor hailing from Ibaraki, Japan, has made significant contributions to the field of medicine with his groundbreaking innovations in antidementia medicaments.

Latest Patents: Yukiko Sugaya's latest patents include a percutaneously applicable preparation and suppository containing an antidementia medicament. These inventions revolutionize the way antidementia medications are administered, utilizing unique formulations incorporating various components for enhanced efficacy.

Career Highlights: Yukiko Sugaya is a valued member of Eisai Company, Limited, a renowned pharmaceutical company. His innovative work at Eisai has led to the development of novel medical solutions that have the potential to improve the lives of countless individuals suffering from dementia.

Collaborations: Throughout his career, Yukiko Sugaya has collaborated closely with esteemed colleagues such as Naokazu Murahashi and Akira Kato. Together, they have pushed the boundaries of pharmaceutical research and development, striving to create innovative treatments for complex neurological disorders.

Conclusion: In conclusion, Yukiko Sugaya's dedication to innovation and his passion for advancing medical science have positioned him as a key figure in the realm of antidementia medications. His patents, collaborations, and contributions at Eisai Company, Limited, underscore his commitment to pioneering solutions that address critical healthcare needs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…